You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / LUPIN

LUPIN
Intrinsic Value | Fundamental Analysis

Returns | 1W : 1.1% , 1M : 6.1%,1Y : 34.7%
BOM : 500257     NSE : LUPIN    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Apr 22,2021
Price(EOD): Rs. 1,061.30
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
MarketCap: Rs. 48,151.18 Cr
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
LUPIN 1.1% 6.1% 34.7%
SUN PHARMACEUTICAL INDUSTRIES 1.2% 11.4% 36.3%
DR REDDYS LABORATORIES 7.4% 23.5% 34.1%
DIVIS LABORATORIES -0.8% 14.8% 61.7%
CIPLA 3.3% 25.1% 62.3%
BIOCON -1.2% 2.6% 12.1%
AUROBINDO PHARMA 8.6% 23.1% 82.7%
TORRENT PHARMACEUTICALS 0.4% 8.8% 11.6%
CADILA HEALTHCARE 9.6% 31.5% 67%

FUNDAMENTAL ANALYSIS OF LUPIN

 
Fundamentals Score
[Last Annual Data : Mar2020 | TTM
Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More
]
Show Me the Stocks with Fundamentals better than LUPIN Premium


VALUATION OF LUPIN

 
Valuation Score
RatioValue
P/E
P/B
P/S
-
P/E Calculated based on EPS of -5.95
[ Mar2020 - Consolidated Results ]

3.9
P/B Calculated based on Book Value of 272.01
[ Mar2020 - Consolidated Results ]

3.11
P/S Calculated based on Revenues of 15502.5 Cr
[ TTM - Consolidated Results ]

Show Me the Stocks with Valuation better than LUPIN Premium


FAIR VALUE OF LUPIN

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
230%
-1%
4%

SHARE PRICE MOMENTUM OF LUPIN

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
0
0
0
-
0.51
0.63
0.53
0.56
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
0 %
As on : Sep2020

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Consolidated 1 Qtr Growth 4 Qtr Growth
Revenue
Op Profit
EBIDT
Net Income
4.76%
31.97%
45.83%
107.05%
6.58%
53.04%
-586.62%
-150.43%
QtrlyTrend
4
Latest Qtr: Dec2020

LUPIN related INDICES

BSE Indices1W1M1Y
S&P BSE HEALTHCARE 3.7% 15.3% 56.9%
S&P BSE MOMENTUM 0.5% 10.6% 36%
S&P BSE QUALITY 0.1% 4.4% 54.5%
S&P BSE SENSEX NEXT 50 -0.7% -0.6% 54.3%
S&P BSE ALLCAP -0.8% -0.3% 59.7%
S&P BSE GREENEX -0.9% 2.2% 63.5%
S&P BSE 500 -0.9% -0.4% 58.8%
S&P BSE 250 LARGEMIDCAP -0.9% -0.4% 57.2%
S&P BSE 200 -1% -0.5% 56.9%
S&P BSE LARGE MIDCAP -1% -0.7% 55.6%
S&P BSE CARBONEX -1.1% -1% 56.2%
S&P BSE 100 LARGECAP TMC -1.1% -0.7% 53.9%
S&P BSE 100 -1.1% -0.9% 54.3%
S&P BSE LARGECAP -1.2% -0.9% 53.7%
NSE Indices1W1M1Y
NIFTY PHARMA 3% 16.2% 46.8%
NIFTY ALPHA LOW-VOLATILTY 30 0.4% 4.3% 39.7%
NIFTY NEXT 50 -0.1% 1.6% 46.2%
NIFTY 100 EQUAL WEIGHT -0.3% 1.2% 60.5%
NIFTY 500 -0.9% -0.4% 58.3%
NIFTY LARGE MIDCAP 250 -0.9% -1.7% 65%
NIFTY 200 -1% -0.4% 55.9%
NIFTY 100 -1.1% -0.7% 53.2%

FAQ [Frequently Asked Questions]


Is LUPIN good for long term investment?

As on 22-Apr-2021, the Fundamentals of LUPIN are Average and hence you can wait for the results to improve to invest for long term ! See Financial Performance of LUPIN . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is LUPIN UnderValued or OverValued?

As on 22-Apr-2021, LUPIN is Fairly Valued and investors can wait for the buying opportunity once it becomes under valued!

What is the Intrinsic Value of LUPIN ?

As on 22-Apr-2021, the Intrinsic Value of LUPIN is Rs. 1,021.66 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 322.04
Fair Value [Median EV / Sales Model] : Rs. 1,069.01
Fair Value [Median Price / Sales Model] : Rs. 1,021.66
Median Fair Value of LUPIN : Rs. 1,021.66

Is LUPIN trading at a Premium or Discount?

As on 22-Apr-2021, LUPIN is trading at a Premium of 4% based on the Median Intrinsic Value!

Is it right time to buy LUPIN shares?

As on 22-Apr-2021, LUPIN is Fairly Valued and investors can wait for the buying opportunity once it becomes under valued!

What is the Financial Performance of Industry Peers of LUPIN?

Check out Financials of Industry Peers using below links:
Financials of SUN PHARMACEUTICAL INDUSTRIES LTD
Financials of DR REDDYS LABORATORIES LTD
Financials of DIVIS LABORATORIES LTD
Financials of CIPLA LTD
Financials of BIOCON LTD
Financials of AUROBINDO PHARMA LTD
Financials of TORRENT PHARMACEUTICALS LTD
Financials of CADILA HEALTHCARE LTD
Financials of ABBOTT INDIA LTD
Financials of ALKEM LABORATORIES LTD

What are the Frequent Comparisons with LUPIN?

LUPIN LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DR REDDYS LABORATORIES LTD
LUPIN LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD
LUPIN LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD
LUPIN LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs BIOCON LTD
LUPIN LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs AUROBINDO PHARMA LTD
LUPIN LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs TORRENT PHARMACEUTICALS LTD
LUPIN LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CADILA HEALTHCARE LTD
LUPIN LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs ABBOTT INDIA LTD
LUPIN LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs ALKEM LABORATORIES LTD

Open Demat Account & Start Investing
    Affiliate Links

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z